Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hye Bin Yoo, Jennifer DiMuzio & Francesca M. Filbey. (2020) Interaction of Cannabis Use and Aging: From Molecule to Mind. Journal of Dual Diagnosis 16:1, pages 140-176.
Read now
Read now
Jacob T. Borodovsky & Alan J. Budney. (2018) Cannabis regulatory science: risk–benefit considerations for mental disorders. International Review of Psychiatry 30:3, pages 183-202.
Read now
Read now
Derick Wade. (2012) Evaluation of the safety and tolerability profile of Sativex®: is it reassuring enough?. Expert Review of Neurotherapeutics 12:sup4, pages 9-14.
Read now
Read now
Philip Robson. (2011) Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Expert Opinion on Drug Safety 10:5, pages 675-685.
Read now
Read now
Articles from other publishers (66)
Hania Shahzad, Maximillian Lee, Vikas Munjal, Cole Veliky & Elizabeth Yu. (2023) Unlocking the Healing Potential. JBJS Reviews 11:11.
Crossref
Crossref
Kelsey G. Guenther, Zhili Xu, Julian Romero, Cecilia J. Hillard, Ken Mackie & Andrea G. Hohmann. (2023) Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain. Neuropharmacology 237, pages 109601.
Crossref
Crossref
Lee Johnson, Marc Malone, Erik Paulson, Josh Swider, David Marelius, Susan Andersen & Dominic Black. (2023) Potency and safety analysis of hemp delta-9 products: the hemp vs. cannabis demarcation problem. Journal of Cannabis Research 5:1.
Crossref
Crossref
Hui Xu, Max M. Owens, Troy Farncombe, Michael Noseworthy & James MacKillop. (2023) Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies. Journal of Psychiatric Research 162, pages 44-56.
Crossref
Crossref
Siyuan Shen, Chang Zhao, Chao Wu, Suyue Sun, Ziyan Li, Wei Yan & Zhenhua Shao. (2023) Allosteric modulation of G protein-coupled receptor signaling. Frontiers in Endocrinology 14.
Crossref
Crossref
Daniel Feingold & Or Gliksberg. 2023. Medicinal Usage of Cannabis and Cannabinoids. Medicinal Usage of Cannabis and Cannabinoids
105
116
.
Mack Elijah Bozman, Senthil Vel Rajan Rajaram Manoharan & Tarak Vasavada. (2022) Marijuana variant of concern: Delta 8-tetrahydrocannabinol (Delta-8-THC, Δ8-THC). Psychiatry Research Case Reports 1:2, pages 100028.
Crossref
Crossref
Diana Buitrago-Garcia, Guillermo Sánchez Vanegas, Paula Alejandra Sánchez Correa, Stela del pilar Baracaldo, Santiago Felipe Gallego Gallego & Lone Baandrup. (2022) Cannabidiol for people with schizophrenia. Cochrane Database of Systematic Reviews 2022:11.
Crossref
Crossref
Rupak Desai, Akhil Jain, Waleed Sultan, Zainab Gandhi, Athul Raj Raju, Vivek Joseph Varughese, Geethu Jnaneswaran, Charu Agarwal, Bisharah Rizvi, Zeeshan Mansuri, Puneet Gupta, Gautam Kumar & Rajesh Sachdeva. (2022) Hypertensive Crisis-Related Hospitalizations and Subsequent Major Adverse Cardiac Events in Young Adults with Cannabis Use Disorder: A Nationwide Analysis. Medicina 58:10, pages 1465.
Crossref
Crossref
Ahmad Salimi, Mohammad Shabani & Elham Mojarad Aylar. (2022) Inhibition of mitochondrial permeability transition pore and antioxidant effect of Delta-9-tetrahydrocannabinol reduces aluminium phosphide-induced cytotoxicity and dysfunction of cardiac mitochondria. Pesticide Biochemistry and Physiology 184, pages 105117.
Crossref
Crossref
Catherine F. Moore, Jeffrey W. Stiltner, Catherine M. Davis & Elise M. Weerts. (2021) Translational models of cannabinoid vapor exposure in laboratory animals. Behavioural Pharmacology 33:2&3, pages 63-89.
Crossref
Crossref
Jolanta B. Zawilska, Katarzyna Kuczyńska, Jessica Bratzu & Liana Fattore. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1323
1353
.
Jeffery J. Wilson & Michael Ferguson. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions
49
65
.
Mary-Ann Fitzcharles, Frank Petzke, Thomas R. Tölle & Winfried Häuser. (2021) Cannabis-Based Medicines and Medical Cannabis in the Treatment of Nociplastic Pain. Drugs 81:18, pages 2103-2116.
Crossref
Crossref
M. L. Drennan, H. C. Karoly, A. D. Bryan, K. E. Hutchison & L. C. Bidwell. (2021) Acute objective and subjective intoxication effects of legal-market high potency THC-dominant versus CBD-dominant cannabis concentrates. Scientific Reports 11:1.
Crossref
Crossref
Katina C. Calakos, Heather Liu, Yihuan Lu, Jon Mikael Anderson, David Matuskey, Nabeel Nabulsi, Yunpeng Ye, Patrick D. Skosnik, Deepak Cyril D’Souza, Evan D. Morris, Kelly P. Cosgrove & Ansel T. Hillmer. (2021) Assessment of transient dopamine responses to smoked cannabis. Drug and Alcohol Dependence 227, pages 108920.
Crossref
Crossref
Kyle A. Windisch, Sanoara Mazid, Megan A. Johnson, Elina Ashirova, Yan Zhou, Lennox Gergoire, Sydney Warwick, Bruce S. McEwen, Mary Jeanne Kreek & Teresa A. Milner. (2021) Acute Delta 9‐tetrahydrocannabinol administration differentially alters the hippocampal opioid system in adult female and male rats. Synapse 75:10.
Crossref
Crossref
Lucia Sideli, Giulia Trotta, Edoardo Spinazzola, Caterina La Cascia & Marta Di Forti. (2021) Adverse effects of heavy cannabis use: even plants can harm the brain. Pain 162:1, pages S97-S104.
Crossref
Crossref
Douglas J. Hermes, Barkha J. Yadav-Samudrala, Changqing Xu, Jacqueline E. Paniccia, Rick B. Meeker, Michael L. Armstrong, Nichole Reisdorph, Benjamin F. Cravatt, Ken Mackie, Aron H. Lichtman, Bogna M. Ignatowska-Jankowska, Donald T. Lysle & Sylvia Fitting. (2021) GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration. Experimental Neurology 341, pages 113699.
Crossref
Crossref
Andrew J. Kesner & David M. Lovinger. (2021) Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings. Journal of Neurochemistry 157:5, pages 1674-1696.
Crossref
Crossref
Marci M. Loiselle, Shaina Gulin, Terra Rose, Eileen Burker, Lauren Bolger & Patrick Smith. (2021) The relationship between marijuana use and psychosocial variables in living kidney donor candidates. Clinical Transplantation 35:5.
Crossref
Crossref
Ruchi Agrawal, Yunus Gonal Yusufsaheb, Naveen Narasimhamurthy, Afreen Begum Hasansab Itagi, Reena Kulshrestha & Santosh Rayagouda Patil. (2021) Anti-Microbial Activity of Hempseed Oil and Sage Oil against Streptococcus mutans and Candida albicans: An In-Vitro Study. Pesquisa Brasileira em Odontopediatria e Clínica Integrada 21.
Crossref
Crossref
Jolanta B. Zawilska, Katarzyna Kuczyńska, Jessica Bratzu & Liana Fattore. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
31
.
Perry M. Duncan. 2020. Substance Use Disorders. Substance Use Disorders.
Marco Echeverria-Villalobos, Alexandre B. Todeschini, Nicoleta Stoicea, Juan Fiorda-Diaz, Tristan Weaver & Sergio D. Bergese. (2019) Perioperative care of cannabis users: A comprehensive review of pharmacological and anesthetic considerations. Journal of Clinical Anesthesia 57, pages 41-49.
Crossref
Crossref
Alan J. Budney, Jacob T. Borodovsky & Ashley A. Knapp. 2019. Cannabis Use Disorders. Cannabis Use Disorders
85
91
.
Fabiana Plescia, Fulvio Plescia, Demetrio Raffa, Angela Cavallaro, Gianluca Lavanco, Benedetta Maggio, Maria Valeria Raimondi, Giuseppe Daidone, Anna Brancato & Carla Cannizzaro. (2018) The role of (E)-6-chloro-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-2-styrylquinazolin-4(3H)-one in the modulation of cannabinoidergic system. A pilot study. Pharmacological Reports 70:6, pages 1124-1132.
Crossref
Crossref
Rimas A. Kubilius, Paul M. Kaplick & Carsten T. Wotjak. (2018)
Highway to hell or magic smoke? The dose-dependence of Δ
9
-THC in place conditioning paradigms
. Learning & Memory 25:9, pages 446-454.
Crossref
Crossref
Ziva D. Cooper, Justin L. Poklis & Fei Liu. (2018) Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073. Neuropharmacology 134, pages 92-100.
Crossref
Crossref
Noureldin Saleh, Oliver Hucke, Gert Kramer, Esther Schmidt, Florian Montel, Radoslaw Lipinski, Boris Ferger, Timothy Clark, Peter W. Hildebrand & Christofer S. Tautermann. (2018) Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Angewandte Chemie International Edition 57:10, pages 2580-2585.
Crossref
Crossref
Noureldin Saleh, Oliver Hucke, Gert Kramer, Esther Schmidt, Florian Montel, Radoslaw Lipinski, Boris Ferger, Timothy Clark, Peter W. Hildebrand & Christofer S. Tautermann. (2018) Multiple Binding Sites Contribute to the Mechanism of Mixed Agonistic and Positive Allosteric Modulators of the Cannabinoid CB1 Receptor. Angewandte Chemie 130:10, pages 2610-2615.
Crossref
Crossref
Alan J. Budney & Jacob T. Borodovsky. (2017) The potential impact of cannabis legalization on the development of cannabis use disorders. Preventive Medicine 104, pages 31-36.
Crossref
Crossref
Mike BennettJudith A. PaiceMark Wallace. (2017) Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives. American Society of Clinical Oncology Educational Book:37, pages 705-713.
Crossref
Crossref
Rajesh K. Joshi. 2017. Pharmaceutical Sciences. Pharmaceutical Sciences
425
458
.
Rajesh K. Joshi. 2017. Recent Advances in Drug Delivery Technology. Recent Advances in Drug Delivery Technology
229
262
.
Arthur Robin WilliamsMark OlfsonJune H. KimSilvia S. MartinsHerbert D. Kleber. (2016) Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer ‘Medicalized’ Programs. Health Affairs 35:3, pages 480-488.
Crossref
Crossref
Margaret Haney & A Eden Evins. (2015) Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed. Neuropsychopharmacology 41:2, pages 393-401.
Crossref
Crossref
Bogna M Ignatowska-Jankowska, Gemma L Baillie, Steven Kinsey, Molly Crowe, Sudeshna Ghosh, Robert A Owens, Imad M Damaj, Justin Poklis, Jenny L Wiley, Matteo Zanda, Chiara Zanato, Iain R Greig, Aron H Lichtman & Ruth A Ross. (2015) A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects. Neuropsychopharmacology 40:13, pages 2948-2959.
Crossref
Crossref
Margaret C. Wardle, Benjamin A. Marcus & Harriet de Wit. (2015) A Preliminary Investigation of Individual Differences in Subjective Responses to D-Amphetamine, Alcohol, and Delta-9-Tetrahydrocannabinol Using a Within-Subjects Randomized Trial. PLOS ONE 10:10, pages e0140501.
Crossref
Crossref
Germán López-Cortacans, Rosario Pérez García & Albert Pagès Artuñedo. (2015) Debut de un ataque de pánico en adolescente de 15 años inducido por consumo de cannabis: abordaje desde la atención primaria. FMC - Formación Médica Continuada en Atención Primaria 22:6, pages 318-321.
Crossref
Crossref
LV Panlilio, SR Goldberg & Z Justinova. (2015) Cannabinoid abuse and addiction: Clinical and preclinical findings. Clinical Pharmacology & Therapeutics 97:6, pages 616-627.
Crossref
Crossref
Katherine A. Scott, Angus G. Dalgleish & Wai M. Liu. (2014) The Combination of Cannabidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model. Molecular Cancer Therapeutics 13:12, pages 2955-2967.
Crossref
Crossref
George Panagis, Brian Mackey & Styliani Vlachou. (2014) Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future. Frontiers in Psychiatry 5.
Crossref
Crossref
Selcuk Ozyurt, Fatma Muderrisoglu, Murat Ermete & Fatma Afsar. (2014) Cannabis-induced erythema multiforme-like recurrent drug eruption. International Journal of Dermatology 53:1, pages e22-e23.
Crossref
Crossref
Andrew J. Saxon & Kendall W. Browne. (2014) Marijuana not ready for prime time as an analgesic. General Hospital Psychiatry 36:1, pages 4-6.
Crossref
Crossref
Muhammad T. AkhtarShaukat AliHassan RashidiFrank van der KooyRobert VerpoorteMichael K. Richardson. (2013) Developmental Effects of Cannabinoids on Zebrafish Larvae. Zebrafish 10:3, pages 283-293.
Crossref
Crossref
Ziva D Cooper, Sandra D Comer & Margaret Haney. (2013) Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers. Neuropsychopharmacology 38:10, pages 1984-1992.
Crossref
Crossref
Joshua A. Lile, Thomas H. Kelly, Richard J. Charnigo, Audra L. Stinchcomb & Lon R. Hays. (2013)
Pharmacokinetic and Pharmacodynamic Profile of Supratherapeutic Oral Doses of Δ
9
-THC in Cannabis Users
. The Journal of Clinical Pharmacology 53:7, pages 680-690.
Crossref
Crossref
Gillinder Bedi, Ziva D. Cooper & Margaret Haney. 2013. Interventions for Addiction. Interventions for Addiction
397
406
.
Ryan G. Vandrey & Alan J. Budney. 2010. Encyclopedia of Psychopharmacology. Encyclopedia of Psychopharmacology
1
6
.
Tomohisa Mori, Masahiro Shibasaki, Minako Abe, Yuya Udagawa & Tsutomu Suzuki. (2012) Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals. Synapse 66:11, pages 931-937.
Crossref
Crossref
Michael E Ballard, Gillinder Bedi & Harriet de Wit. (2012) Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images. Journal of Psychopharmacology 26:10, pages 1289-1298.
Crossref
Crossref
J Hirvonen, R S Goodwin, C-T Li, G E Terry, S S Zoghbi, C Morse, V W Pike, N D Volkow, M A Huestis & R B Innis. (2011) Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry 17:6, pages 642-649.
Crossref
Crossref
J. Michael Bostwick. (2012) Blurred Boundaries: The Therapeutics and Politics of Medical Marijuana. Mayo Clinic Proceedings 87:2, pages 172-186.
Crossref
Crossref
Yehoshua Zarfin, Enav Yefet, Said Abozaid, Wael Nasser, Tamer Mor & Yoram Finkelstein. (2012) Infant with altered consciousness after cannabis passive inhalation. Child Abuse & Neglect 36:2, pages 81-83.
Crossref
Crossref
Louis A. Pagliaro & Ann Marie Pagliaro. 2011. Handbook of Child and Adolescent Drug and Substance Abuse. Handbook of Child and Adolescent Drug and Substance Abuse
371
453
.
Leslie Iversen. 2011. Marijuana and Madness. Marijuana and Madness
1
16
.
O. Sagredo. (2011) Efectos farmacológicos y fisiológicos del consumo de cannabis. Trastornos Adictivos 13:3, pages 94-96.
Crossref
Crossref
Adam Stewart, Keith Wong, Jonathan Cachat, Siddharth Gaikwad, Evan Kyzar, Nadine Wu, Peter Hart, Valerie Piet, Eli Utterback, Marco Elegante, David Tien & Allan V. Kalueff. (2011) Zebrafish models to study drug abuse-related phenotypes. revneuro 22:1, pages 95-105.
Crossref
Crossref
José Luis G. Pinho Costa, Lucas O. Maia, P. Orlandi-Mattos, João C. Villares & Manuel A. Fernandez Esteves. (2011) Neurobiologia da Cannabis: do sistema endocanabinoide aos transtornos por uso de Cannabis. Jornal Brasileiro de Psiquiatria 60:2, pages 111-122.
Crossref
Crossref
Joshua A. Lile, Thomas H. Kelly & Lon R. Hays. (2010) Substitution Profile of the Cannabinoid Agonist Nabilone in Human Subjects Discriminating Δ9-Tetrahydrocannabinol. Clinical Neuropharmacology 33:5, pages 235-242.
Crossref
Crossref
Celia JA Morgan, Tom P Freeman, Gráinne L Schafer & H Valerie Curran. (2010) Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis. Neuropsychopharmacology 35:9, pages 1879-1885.
Crossref
Crossref
Alan J. Budney, Ryan G. Vandrey & Catherine Stanger. (2010) Intervenções farmacológica e psicossocial para os distúrbios por uso da cannabis. Revista Brasileira de Psiquiatria 32:suppl 1, pages 546-555.
Crossref
Crossref
Nikolai Zvonok, Wei Xu, John Williams, David R. Janero, Srinivasan C. Krishnan & Alexandros Makriyannis. (2010) Mass Spectrometry-Based GPCR Proteomics: Comprehensive Characterization of the Human Cannabinoid 1 Receptor. Journal of Proteome Research 9:4, pages 1746-1753.
Crossref
Crossref
Jonathan Cachat, Peter Canavello, Marco Elegante, Brett Bartels, Peter Hart, Carisa Bergner, Rupert Egan, Ashley Duncan, David Tien, Amanda Chung, Keith Wong, Jason Goodspeed, Julia Tan, Chelsea Grimes, Salem Elkhayat, Christopher Suciu, Michael Rosenberg, Kyung Min Chung, Ferdous Kadri, Sudipta Roy, Siddharth Gaikwad, Adam Stewart, Ivan Zapolsky, Thomas Gilder, Sopan Mohnot, Esther Beeson, Hakima Amri, Zofia Zukowska, R. Denis Soignier & Allan V. Kalueff. (2010) Modeling withdrawal syndrome in zebrafish. Behavioural Brain Research 208:2, pages 371-376.
Crossref
Crossref
Didier Jutras-AswadM.D. M. ScM.D. M. Sc, Julie BruneauM.D. M. ScM.D. M. Sc & Yasmin L. HurdPh. D.Ph. D.. (2010) Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention. Drogues, santé et société 8:2, pages 27-73.
Crossref
Crossref